GelTex Pharmaceuticals

company

About

GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$6.80M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 1992
Number Of Employee
1 - 10
Operating Status
Active

GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract. It also develops small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Its focus areas include hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases.


GelTex Pharmaceutics is based in Waltham Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$6.80M
GelTex Pharmaceuticals has raised a total of $6.80M in funding over 2 rounds. Their latest funding was raised on Sep 9, 1993 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 9, 1993 Series Unknown $6.80M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
GelTex Pharmaceuticals is funded by 2 investors. Norwest Venture Partners and Biotechnology Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Series Unknown
Biotechnology Investments Series Unknown